Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VINCA study of one-hour versus short vincristine infusion in children with cancer
NL-OMON47569Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Sep 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vincristine in acute lymphoblastic leukemia (ALL), Wilms' tumor, low-grade glioma (LGG) and 3 more (2 arms), sponsored by Vrije University Medical Center. Primary endpoints: Peripheral neuropathy, Peripheral motor neuropathy and 3 more. Started Sep 2014; status: active, not recruiting.
02
Drugs
vincristine
03
Conditions
acute lymphoblastic leukemia (ALL)Wilms' tumorlow-grade glioma (LGG)Hodgkin lymphoma (HL)rhabdomyosarcoma (RMS)
Beyond the preview
Go deeper on NL-OMON47569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47569.